Suppr超能文献

非甾体抗炎药和抗高血压药。

Nonsteroidal anti-inflammatory drugs and antihypertensives.

作者信息

Houston M C

机构信息

Vanderbilt Clinic, Vanderbilt University Medical Center, Nashville, TN.

出版信息

Am J Med. 1991 May 17;90(5A):42S-47S. doi: 10.1016/0002-9343(91)90485-g.

Abstract

Approximately 60 million people in the United States have hypertension (BP greater than or equal to 140/90 mm Hg), 40 million have arthritis clinically suitable for nonsteroidal anti-inflammatory drug (NSAID) therapy, and millions take NSAIDs for nonarthritic conditions, creating considerable potential for concomitant administration of NSAIDs and antihypertensive agents. It is estimated that more than 20 million people are on concurrent therapy. Most NSAIDs produce mild elevations of normal blood pressure levels and can partially or completely antagonize the effects of many antihypertensive drugs. The effect on blood pressure can vary from no effect to hypertensive crisis. In pooled studies, the average increase in mean arterial pressure was 10 mm Hg, and duration was short-lived or chronic. Significant interactions occur in about 1% of patients per year. The risk is greatest in the elderly, blacks, and patients with low-renin hypertension. NSAIDs may block the antihypertensive effects of thiazide and loop diuretics, beta-adrenergic blockers, alpha-adrenergic blockers, and angiotensin-converting enzyme inhibitors. No interactions have been reported with centrally acting alpha agonists or the calcium channel blockers. The mechanism of the hypertensive effects of NSAIDs seem primarily related to their ability to block the cyclo-oxygenase pathway of arachidonic acid metabolism, with a resultant decrease in prostaglandin formation. The prostaglandins are important in normal modulation of renal and systemic vascular dilatation, glomerular filtration, tubular secretion of salt and water, adrenergic neurotransmission, and the renin-angiotensin-aldosterone system. Blockade of salutary effects of prostaglandins by NSAIDs results in a complex series of events culminating in attenuation of the effects of many antihypertensive agents. High-risk patients treated with NSAIDs should be identified and have blood pressure, renal function, and serum potassium frequently monitored.

摘要

在美国,约6000万人患有高血压(血压大于或等于140/90毫米汞柱),4000万人患有关节炎且临床上适合使用非甾体抗炎药(NSAID)治疗,还有数百万人因非关节炎病症服用NSAIDs,这使得NSAIDs与抗高血压药物联合使用的可能性相当大。据估计,超过2000万人正在接受联合治疗。大多数NSAIDs会使正常血压水平轻度升高,并可能部分或完全拮抗许多抗高血压药物的作用。对血压的影响可能从无影响到高血压危象不等。在汇总研究中,平均动脉压的平均升高幅度为10毫米汞柱,持续时间为短期或慢性。每年约1%的患者会发生显著相互作用。风险在老年人、黑人以及低肾素性高血压患者中最高。NSAIDs可能会阻断噻嗪类和襻利尿剂、β肾上腺素能阻滞剂、α肾上腺素能阻滞剂以及血管紧张素转换酶抑制剂的抗高血压作用。尚未有关于中枢性α激动剂或钙通道阻滞剂相互作用的报道。NSAIDs产生高血压作用的机制似乎主要与其阻断花生四烯酸代谢的环氧化酶途径的能力有关,从而导致前列腺素生成减少。前列腺素在肾脏和全身血管舒张、肾小球滤过、盐和水的肾小管分泌、肾上腺素能神经传递以及肾素 - 血管紧张素 - 醛固酮系统的正常调节中起着重要作用。NSAIDs阻断前列腺素的有益作用会导致一系列复杂事件,最终削弱许多抗高血压药物的作用。使用NSAIDs治疗的高危患者应被识别出来,并经常监测血压、肾功能和血清钾。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验